This may give an explanation why Ng ELISAs targeting either full‐length Ng or the sum of C‐terminal and full‐length Ng have been reported to have the same predictive power for distinguishing AD from controls (Willemse et al., 2018). The gene discussed is NRGN; the disease is Alzheimer disease.